The Board could issue an aggregate maximum number of 106.2 million new shares in one or several stages. The money would finance the continued development of the group.
At the Friday closing price, of RON11.04 per share, the maximum number of new shares would correspond to a sum of around RON1,172 million (EUR219 million), but the final value depends on the price to be set.
The announcement comes after in the first six months of the year MedLife boosted its turnover by 10.5%, to RON1,739 million (EUR325 million), but reported a loss of RON35 million (EUR6 million), from a RON11 million loss in the previous year.
(English version by Catalina Apostoiu)